Levosimendan

Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients

Interest of Levosimendan in Reducing Weaning Failures of ExtraCorporeal Life Support - ECLS

Shorter Weaning From Invasive Ventilation With Levosimendan

Levosimendan in Acute Decompensated Heart Failure

Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function

Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage

Levosimendan In Ambulatory Heart Failure Patients

Effect Levosimendan Administration on Postoperative NT-proBNP in Cardiac Risk Patients

LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?

Levosimendan Versus Combination With Magnesium Sulphate on Spine Protection by NIRS in Infants Undergoing Coarctectomy

Interest of Levosimendan Preconditioning for Cardiac Surgery Under CEC in Heart Failure Patients With Impaired Ejection Fraction

Levosimendan Versus Placebo Before Tricuspid Valve Surgery in Patients With Right Ventricular Dysfunction

Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Efficacy and Clinical Outcomes of Levosimendan in E-CPR

Impact of Levosimendan Preconditioning on Critical Care and In-hospital Lengths of Stay After Cardiac Surgery With Bypass Surgery

Acute and Chronic Protective Effects of Peri-interventional Administration of Levosimendan in ST Elevation Myocardial Infarctions

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS